Literature DB >> 8314439

Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type 1 (insulin-dependent) diabetes mellitus.

E Thorsby1, K S Rønningen.   

Abstract

Genes in the HLA complex are by far the most important in determining genetic predisposition or resistance to Type 1 (insulin-dependent) diabetes mellitus. In this review evidence is presented that the HLA genes mainly involved are those encoding some particular HLA-DQ molecules. Both among Black, Caucasian and Japanese subjects particular cis or trans encoded DQ molecules are significantly associated with susceptibility, while others are associated with resistance. A varying degree of susceptibility or resistance seems to be conferred by these DQ molecules, where those determining resistance are dominant over those determining susceptibility. The degree of genetic predisposition to develop Type 1 diabetes carried by an individual would therefore be the result of his or her particular combination of DQ molecules. A primary association to particular DQ molecules explains previously found associations to other HLA complex genes by linkage disequilibrium. Some mechanisms by which particular DQ molecules may determine susceptibility or resistance are also discussed. Potential islet beta-cell reactive CD4+ T-cells may escape negative selection (deletion) in the thymus, but normally become anergized or remain ignorant extra-thymically. However, under particular circumstances they may be triggered. The DQ molecules associated with Type 1 diabetes susceptibility may preferentially bind and present triggering and/or beta-cell derived peptides to such T cells, causing beta-cell destruction. The finding that particular DQ molecules determine susceptibility may lead to new methods of preventing development of Type 1 diabetes in susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8314439     DOI: 10.1007/bf00402270

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  43 in total

1.  Nomenclature for factors of the HLA system, 1991. WHO Nomenclature Committee for factors of the HLA system.

Authors:  J G Bodmer; S G Marsh; E D Albert; W F Bodmer; B Dupont; H A Erlich; B Mach; W R Mayr; P Parham; T Sasazuki
Journal:  Tissue Antigens       Date:  1992-04

2.  T cells recognizing an HLA-DQ alpha beta heterodimer encoded in cis by the DR4DQw4 haplotype and in trans by DR4DQw8/DRw8DQw4 heterozygous cells.

Authors:  H A Gjertsen; K E Lundin; K S Rønningen; G Gaudernack; E Thorsby
Journal:  Hum Immunol       Date:  1991-03       Impact factor: 2.850

Review 3.  An overview on possible mechanisms of destruction of the insulin-producing beta cell.

Authors:  A Cooke
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

4.  Two distinct HLA-DR3 haplotypes are associated with age related heterogeneity in type 1 (insulin-dependent) diabetes.

Authors:  I Deschamps; A Marcelli-Barge; J C Poirier; O Cohen-Haguenauer; H Abderrahim; D Cohen; H Lestradet; J Hors
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122

5.  Primary association of HLA-DQw8 with type I diabetes in DR4 patients.

Authors:  D Owerbach; S Gunn; K H Gabbay
Journal:  Diabetes       Date:  1989-07       Impact factor: 9.461

6.  A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.

Authors:  O Cohen-Haguenauer; E Robbins; C Massart; M Busson; I Deschamps; J Hors; J M Lalouel; J Dausset; D Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

7.  A diabetes-susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles.

Authors:  M J Sheehy; S J Scharf; J R Rowe; M H Neme de Gimenez; L M Meske; H A Erlich; B S Nepom
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  High frequency of aspartic acid at position 57 of HLA-DQ beta-chain in Japanese IDDM patients and nondiabetic subjects.

Authors:  T Awata; T Kuzuya; A Matsuda; Y Iwamoto; Y Kanazawa; M Okuyama; T Juji
Journal:  Diabetes       Date:  1990-02       Impact factor: 9.461

Review 9.  A unified hypothesis for the complex genetics of HLA associations with IDDM.

Authors:  G T Nepom
Journal:  Diabetes       Date:  1990-10       Impact factor: 9.461

10.  Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as type 1 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population.

Authors:  J L Vicario; J Martinez-Laso; A Corell; J M Martin-Villa; P Morales; G Lledo; O G Segurado; D de Juan; A Arnaiz-Villena
Journal:  Diabetologia       Date:  1992-05       Impact factor: 10.122

View more
  31 in total

Review 1.  Genetic predisposition to IDDM.

Authors:  S Caillat-Zucman; J F Bach
Journal:  Clin Rev Allergy Immunol       Date:  2000-12       Impact factor: 8.667

Review 2.  Type I (insulin-dependent) diabetes is a Th1- and Th2-mediated autoimmune disease.

Authors:  S T Azar; H Tamim; H N Beyhum; M Z Habbal; W Y Almawi
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

3.  Interplay between genetics and the environment in the development of celiac disease: perspectives for a healthy life.

Authors:  G K Papadopoulos; C Wijmenga; F Koning
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

4.  The association of CTLA-4 and HLA class II autoimmune risk genotype with regulatory T cell marker expression in 5-year-old children.

Authors:  C-O Jonson; M Hedman; M Karlsson Faresjö; R Casas; J Ilonen; J Ludvigsson; O Vaarala
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

5.  The relationship of lmp2 and DR3 genes with susceptibility to type I diabetes mellitus in south China Han population.

Authors:  He-Li Ding; Hua Cheng; Zu-Zhi Fu; Qing-Li Deng; Li YanLAST_NAME> Tang Yan; Tang Yan
Journal:  World J Gastroenterol       Date:  2000-02       Impact factor: 5.742

6.  HLA class II DR-DQ amino acids and insulin-dependent diabetes mellitus: application of the haplotype method.

Authors:  A M Valdes; S McWeeney; G Thomson
Journal:  Am J Hum Genet       Date:  1997-03       Impact factor: 11.025

7.  Genetic predisposition and environmental factors leading to the development of insulin-dependent diabetes mellitus in Chilean children.

Authors:  F Perez-Bravo; E Carrasco; M D Gutierrez-Lopez; M T Martinez; G Lopez; M G de los Rios
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

8.  No difference in the parental origin of susceptibility HLA class II haplotypes among Norwegian patients with insulin-dependent diabetes mellitus.

Authors:  D E Undlien; H E Akselsen; G Joner; K Dahl-Jorgensen; O Aagenaes; O Sovik; E Thorsby; K S Rønningen
Journal:  Am J Hum Genet       Date:  1995-12       Impact factor: 11.025

9.  No significant association between HLA antigens and classic Kaposi sarcoma: molecular analysis of 49 Jewish patients.

Authors:  L Strichman-Almashanu; S Weltfriend; O Gideoni; R Friedman-Birnbaum; S Pollack
Journal:  J Clin Immunol       Date:  1995-07       Impact factor: 8.317

10.  Soluble HLA-DQ2 expressed in S2 cells copurifies with a high affinity insect cell derived protein.

Authors:  Ulrike Jüse; Burkhard Fleckenstein; Elin Bergseng; Ludvig M Sollid
Journal:  Immunogenetics       Date:  2008-11-06       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.